Alzheimer disease and related dementias (ADRDs) are a global medical and public health
challenge. 1 Early and accurate diagnosis of these conditions can mitigate costs and …

Alzheimer's disease (AD) is the only leading cause of death for which no disease-modifying
therapy is currently available. Over the past decade, a string of disappointing clinical trial …

Background and Objectives To determine the relevance of minor neuropsychological deficits
(MNPD) in patients with subjective cognitive decline (SCD) with regard to CSF levels of …

Background The correlation between cognitive function and lipid profiles, including total
cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol …

Introduction This study evaluated the diagnostic accuracy of the Cogstate Brief Battery (CBB)
for mild cognitive impairment (MCI) and prodromal Alzheimer's disease (AD) in a population …

Introduction Timely and accurate diagnosis of the earliest manifestations of Alzheimer's
disease (AD) is critically important. Cognitive challenge tests such as the Loewenstein …

Background Unsupervised online cognitive assessments have demonstrated promise as an
efficient and scalable approach for evaluating cognition in aging, and Alzheimer's disease …

Background: With the arrival of disease-modifying treatments, it is mandatory to find new
cognitive markers that are sensitive to Alzheimer's disease (AD) pathology in preclinical …

Objective: Growing evidence supports the importance of learning as a central deficit in
preclinical/prodromal Alzheimer's disease. The aims of this study were to conduct a series of …

Alzheimer's disease (AD) is a progressive age-related neurodegenerative disorder that
results in irreversible cognitive impairments. Nonetheless, there are numerous sex …